Core Laboratories Inc.
CLB
$12.65
$0.131.04%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.74M | 22.82M | 22.70M | 25.63M | 31.19M |
| Total Receivables | 116.08M | 115.19M | 120.80M | 124.97M | 127.95M |
| Inventory | 57.96M | 57.78M | 54.50M | 58.24M | 59.77M |
| Prepaid Expenses | 10.95M | 11.36M | 9.73M | 10.06M | 10.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.63M | 7.22M | 6.94M | 8.01M | 8.25M |
| Total Current Assets | 214.36M | 214.37M | 214.67M | 226.91M | 237.68M |
|
|
|||||
| Total Current Assets | 214.36M | 214.37M | 214.67M | 226.91M | 237.68M |
| Net Property, Plant & Equipment | 153.26M | 154.69M | 153.79M | 152.01M | 153.04M |
| Long-term Investments | 105.80M | 105.80M | 105.79M | 100.01M | 100.00M |
| Goodwill | 105.80M | 105.80M | 105.79M | 100.01M | 100.00M |
| Total Other Intangibles | 6.75M | 6.89M | 7.12M | 6.11M | 6.17M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 106.61M | 105.98M | 98.22M | 106.32M | 105.23M |
| Total Assets | 586.78M | 587.73M | 584.01M | 591.36M | 602.11M |
|
|
|||||
| Total Accounts Payable | 40.16M | 39.98M | 37.28M | 36.95M | 41.70M |
| Total Accrued Expenses | 25.25M | 26.36M | 30.80M | 27.22M | 28.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.94M | 12.10M | 11.46M | 11.47M | 11.51M |
| Total Finance Division Other Current Liabilities | 23.70M | 26.30M | 26.49M | 20.11M | 22.62M |
| Total Other Current Liabilities | 23.70M | 26.30M | 26.49M | 20.11M | 22.62M |
| Total Current Liabilities | 101.05M | 104.73M | 106.02M | 95.74M | 104.77M |
|
|
|||||
| Total Current Liabilities | 101.05M | 104.73M | 106.02M | 95.74M | 104.77M |
| Long-Term Debt | 113.86M | 114.46M | 110.26M | 114.10M | 124.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 39.31M | 41.29M | 42.31M | 41.53M | 42.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 53.78M | 52.11M | 53.22M | 62.60M | 63.00M |
| Total Liabilities | 308.01M | 312.58M | 311.80M | 313.97M | 334.81M |
|
|
|||||
| Common Stock & APIC | 115.98M | 115.69M | 110.72M | 114.34M | 113.23M |
| Retained Earnings | 176.91M | 171.41M | 172.66M | 173.60M | 159.82M |
| Treasury Stock & Other | -20.22M | -18.22M | -17.39M | -16.60M | -11.77M |
| Total Common Equity | 272.67M | 268.89M | 265.99M | 271.35M | 261.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 272.67M | 268.89M | 265.99M | 271.35M | 261.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 6.10M | 6.26M | 6.22M | 6.04M | 6.02M |
| Total Equity | 278.77M | 275.14M | 272.21M | 277.39M | 267.30M |
|
|
|||||